Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

212 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Three-year outcomes of valoctocogene roxaparvovec gene therapy for hemophilia A.
Madan B, Ozelo MC, Raheja P, Symington E, Quon DV, Leavitt AD, Pipe SW, Lowe G, Kenet G, Reding MT, Mason J, Wang M, von Drygalski A, Klamroth R, Shapiro S, Chambost H, Dunn AL, Oldenburg J, Chou SC, Peyvandi F, Millar CM, Osmond D, Yu H, Dashiell-Aje E, Robinson TM, Mahlangu J. Madan B, et al. J Thromb Haemost. 2024 Jul;22(7):1880-1893. doi: 10.1016/j.jtha.2024.04.001. Epub 2024 Apr 12. J Thromb Haemost. 2024. PMID: 38614387 Free article. Clinical Trial.
Inhibitor development in non-severe haemophilia across Europe.
Fischer K, Iorio A, Lassila R, Peyvandi F, Calizzani G, Gatt A, Lambert T, Windyga J, Gilman EA, Hollingsworth R, Makris M; EUHASS Participants. Fischer K, et al. Thromb Haemost. 2015 Oct;114(4):670-5. doi: 10.1160/TH14-12-1044. Epub 2015 Aug 13. Thromb Haemost. 2015. PMID: 26293381 Free article.
Efficacy, safety, and quality of life 4 years after valoctocogene roxaparvovec gene transfer for severe hemophilia A in the phase 3 GENEr8-1 trial.
Leavitt AD, Mahlangu J, Raheja P, Symington E, Quon DV, Giermasz A, López Fernández MF, Kenet G, Lowe G, Key NS, Millar CM, Pipe SW, Madan B, Chou SC, Klamroth R, Mason J, Chambost H, Peyvandi F, Majerus E, Pepperell D, Rivat C, Yu H, Robinson TM, Ozelo MC. Leavitt AD, et al. Among authors: madan b. Res Pract Thromb Haemost. 2024 Oct 30;8(8):102615. doi: 10.1016/j.rpth.2024.102615. eCollection 2024 Nov. Res Pract Thromb Haemost. 2024. PMID: 39687929 Free PMC article.
Optimized single-cell gates for yeast display screening.
Pan X, de Souza MO, Figueiras FM, Huang A, Banach BB, Wolfe JR, Pirhanov A, Madan B, DeKosky BJ. Pan X, et al. Among authors: madan b. Protein Eng Des Sel. 2024 Dec 12:gzae018. doi: 10.1093/protein/gzae018. Online ahead of print. Protein Eng Des Sel. 2024. PMID: 39667035
Clonal Variant Analysis of Antibody Engineering Libraries.
Fahad AS, Gutiérrez-Gonzalez MF, Madan B, DeKosky BJ. Fahad AS, et al. Among authors: madan b. Cold Spring Harb Protoc. 2024 Nov 25. doi: 10.1101/pdb.prot108626. Online ahead of print. Cold Spring Harb Protoc. 2024. PMID: 39586683
Antibody Data Analysis from Diverse Immune Libraries.
Fahad AS, Gutiérrez-Gonzalez MF, Madan B, DeKosky BJ. Fahad AS, et al. Among authors: madan b. Cold Spring Harb Protoc. 2024 Nov 25. doi: 10.1101/pdb.prot108627. Online ahead of print. Cold Spring Harb Protoc. 2024. PMID: 39586680
212 results